Literature DB >> 24175609

Clinical rehabilitation guidelines for matrix-induced autologous chondrocyte implantation on the tibiofemoral joint.

Peter K Edwards1, Timothy Ackland, Jay R Ebert.   

Abstract

SYNOPSIS: Autologous chondrocyte implantation (ACI) has become an established technique for the repair of full-thickness chondral defects in the knee. Matrix-induced ACI (MACI) is the third and current generation of this surgical technique, and, while postoperative rehabilitation following MACI aims to restore normal function in each patient as quickly as possible by facilitating a healing response without overloading the repair site, current published guidelines appear conservative, varied, potentially outdated, and often based on earlier ACI surgical techniques. This article reviews the existing evidence-based literature pertaining to cell loading and postoperative rehabilitation following generations of ACI. Based on this information, in combination with the technical benefits provided by third-generation MACI in comparison to its surgical predecessors, we present a rehabilitation protocol for patients undergoing MACI in the tibiofemoral joint that has now been implemented for several years by our institution in patients with MACI, with good clinical outcomes.

Entities:  

Mesh:

Year:  2013        PMID: 24175609     DOI: 10.2519/jospt.2014.5055

Source DB:  PubMed          Journal:  J Orthop Sports Phys Ther        ISSN: 0190-6011            Impact factor:   4.751


  16 in total

Review 1.  Disc cell therapies: critical issues.

Authors:  Marta Tibiletti; Nevenka Kregar Velikonja; Jill P G Urban; Jeremy C T Fairbank
Journal:  Eur Spine J       Date:  2014-02-08       Impact factor: 3.134

2.  Advancing biomaterials of human origin for tissue engineering.

Authors:  Fa-Ming Chen; Xiaohua Liu
Journal:  Prog Polym Sci       Date:  2015-03-28       Impact factor: 29.190

3.  Effect of interface mechanical discontinuities on scaffold-cartilage integration.

Authors:  Supansa Yodmuang; Hongqiang Guo; Caroline Brial; Russell F Warren; Peter A Torzilli; Tony Chen; Suzanne A Maher
Journal:  J Orthop Res       Date:  2019-03-20       Impact factor: 3.494

4.  Mechanostimulation changes the catabolic phenotype of human dedifferentiated osteoarthritic chondrocytes.

Authors:  Florian Halbwirth; Eugenia Niculescu-Morzsa; Hannes Zwickl; Christoph Bauer; Stefan Nehrer
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2014-11-07       Impact factor: 4.342

Review 5.  [Cartilage repair of the knee joint].

Authors:  B Rath; J Eschweiler; M Betsch; G Gruber
Journal:  Orthopade       Date:  2017-11       Impact factor: 1.087

6.  Mechano-activated biomolecule release in regenerating load-bearing tissue microenvironments.

Authors:  Ana P Peredo; Yun Kee Jo; Gang Duan; George R Dodge; Daeyeon Lee; Robert L Mauck
Journal:  Biomaterials       Date:  2020-10-10       Impact factor: 12.479

7.  Matrix-induced autologous chondrocyte implantation for the treatment of chondral defects of the knees in Chinese patients.

Authors:  Zhongwen Zhang; Xin Zhong; Huiru Ji; Zibin Tang; Jianpeng Bai; Minmin Yao; Jianlei Hou; Minghao Zheng; David J Wood; Jiazhi Sun; Shu-Feng Zhou; Aibing Liu
Journal:  Drug Des Devel Ther       Date:  2014-12-05       Impact factor: 4.162

Review 8.  Microfracture is more cost-effective than autologous chondrocyte implantation: a review of level 1 and level 2 studies with 5 year follow-up.

Authors:  Tommy Frøseth Aae; Per-Henrik Randsborg; Hilde Lurås; Asbjørn Årøen; Øystein Bjerkestrand Lian
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2017-11-11       Impact factor: 4.342

9.  Neuroleukin/Autocrine Motility Factor Receptor Pathway Promotes Proliferation of Articular Chondrocytes through Activation of AKT and Smad2/3.

Authors:  Kang Tian; Weiliang Zhong; Xifu Zheng; Jinrui Zhang; Pixu Liu; Weiguo Zhang; Han Liu
Journal:  Sci Rep       Date:  2015-10-13       Impact factor: 4.379

10.  Microfluidics‑based optimization of neuroleukin‑mediated regulation of articular chondrocyte proliferation.

Authors:  Kang Tian; Weiliang Zhong; Yingqiu Zhang; Baosheng Yin; Weiguo Zhang; Han Liu
Journal:  Mol Med Rep       Date:  2015-11-10       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.